Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study - Pivonello, Rosario; Bancos, Irina; Feelders, Richard A.; Kargi, Atil Y.; Kerr, Janice M.; Gordon, Murray B.; Mariash, Cary N.; Terzolo, Massimo; Ellison, Noel; Moraitis, Andreas G. (Frontiers in Endocrinology, 2022)